Access to anti-retroviral drugs, female in Rwanda
Rwanda: Access to anti-retroviral drugs, female was 97.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Rwanda, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Rwanda recorded 97.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
The figure is up 4.3% on the previous year and up 56.5% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Rwanda peaked at 97.0% in 2024 and was at its lowest, 0.0%, in 2000.
Rwanda ranks 12th of 141 countries on this measure, in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Rwanda, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 3.0% | — |
| 2005 | 9.0% | +200.0% |
| 2006 | 16.0% | +77.8% |
| 2007 | 21.0% | +31.2% |
| 2008 | 28.0% | +33.3% |
| 2009 | 34.0% | +21.4% |
| 2010 | 39.0% | +14.7% |
| 2011 | 43.0% | +10.3% |
| 2012 | 51.0% | +18.6% |
| 2013 | 56.0% | +9.8% |
| 2014 | 62.0% | +10.7% |
| 2015 | 68.0% | +9.7% |
| 2016 | 75.0% | +10.3% |
| 2017 | 77.0% | +2.7% |
| 2018 | 80.0% | +3.9% |
| 2019 | 82.0% | +2.5% |
| 2020 | 85.0% | +3.7% |
| 2021 | 88.0% | +3.5% |
| 2022 | 91.0% | +3.4% |
| 2023 | 93.0% | +2.2% |
| 2024 | 97.0% | +4.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 11.1% | 0.0% | 34.0% | 10 |
| 2010s | 63.3% | 39.0% | 82.0% | 10 |
| 2020s | 90.8% | 85.0% | 97.0% | 5 |
Countries ranked near Rwanda
More gender data for Rwanda
- Child population (UN estimates and projections) 5,716 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.9861 % change on previous year (2030)
- Population 10,439 (2030)
- Working-age population (UN estimates and projections) 10,439 (2030)
- Population (UN estimates and projections), annual growth rate 2.5 % change on previous year (2030)
- Age population, age 00, female, interpolated 194,446 (2025)
- Age population, age 00, male, interpolated 198,438 (2025)
- Age population, age 01, female, interpolated 191,100 (2025)
- Age population, age 01, male, interpolated 194,971 (2025)
- Age population, age 02, female, interpolated 188,797 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Rwanda?
- Access to anti-retroviral drugs, female in Rwanda was 97.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Rwanda?
- The highest recorded value was 97.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Rwanda?
- The lowest recorded value was 0.0% in 2000.
- How does Rwanda rank for access to anti-retroviral drugs, female?
- Rwanda ranks 12th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Rwanda?
- Over the last ten years it is up 56.5%. The long-run trend across the full record is volatile.
- Where does this Rwanda data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.